Saba Capital Management, L.P. sold HQL

August 29, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 23,723 shares of Abrdn Life Sciences Investors at $13.89 per share, a transaction worth $329.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.